Heartflowinc

Heartflow is a publicly traded medical technology company that makes an AI-driven, non-invasive cardiac test (FFRCT Analysis) used to diagnose and assess coronary artery disease. Its CCTA-based product suite helps clinicians identify arterial blockages, assess blood flow, and characterize plaque, and has been used on over 500,000 patients worldwide with regulatory clearance in multiple countries.